Growth Metrics

Bruker (BRKR) Non-Current Receivables (2023 - 2025)

Bruker filings provide 3 years of Non-Current Receivables readings, the most recent being $102.9 million for Q4 2025.

  • On a quarterly basis, Non-Current Receivables rose 24.73% to $102.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $102.9 million, a 24.73% increase, with the full-year FY2025 number at $102.9 million, up 24.73% from a year prior.
  • Non-Current Receivables hit $102.9 million in Q4 2025 for Bruker, up from $82.5 million in the prior quarter.
  • In the past five years, Non-Current Receivables ranged from a high of $102.9 million in Q4 2025 to a low of $77.2 million in Q4 2023.
  • Median Non-Current Receivables over the past 3 years was $82.5 million (2024), compared with a mean of $87.5 million.
  • Biggest five-year swings in Non-Current Receivables: rose 6.87% in 2024 and later increased 24.73% in 2025.
  • Bruker's Non-Current Receivables stood at $77.2 million in 2023, then rose by 6.87% to $82.5 million in 2024, then grew by 24.73% to $102.9 million in 2025.
  • The last three reported values for Non-Current Receivables were $102.9 million (Q4 2025), $82.5 million (Q4 2024), and $77.2 million (Q4 2023) per Business Quant data.